News
Stocks on Sky High. Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is one of the top-performing companies on Thursday. Sarepta ...
Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options become available today, for the July 25th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...
SRPT stock has cleared six out of the eight parameters to achieve a "Perfect 10" Smart Score. ... XPO Logistics and Sarepta Therapeutics (NASDAQ:SRPT). But before moving ahead, let’s ...
Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options become available today, for the July 3rd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Sarepta Therapeutics Inc (Symbol: SRPT), where a total volume of 46,971 ...
Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options begin trading today, for the August 2025 expiration. One of the key inputs that goes into the price an option buyer is willing ...
Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options become available today, for the August 22nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...
Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options become available today, for the December 15th expiration. One of the key data points that goes into the price an option buyer ...
Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options begin trading today, for the June 2023 expiration. One of the key inputs that goes into the price an option buyer is willing to ...
Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options begin trading today, for the March 2023 expiration. One of the key data points that goes into the price an option buyer is ...
Below is Validea's guru fundamental report for SAREPTA THERAPEUTICS INC (SRPT). Of the 22 guru strategies we follow, SRPT rates highest using our P/B Growth Investor model based on the published ...
Below is Validea's guru fundamental report for SAREPTA THERAPEUTICS INC (SRPT). Of the 22 guru strategies we follow, SRPT rates highest using our P/B Growth Investor model based on the published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results